Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1625
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18449800 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND GDC-0077 | Non-Final OA | Genentech, Inc. |
| 17626699 | YAP Inhibition for Wound Healing | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18277748 | UNSYMMETRIC LINEAR CARBONATE AND METHOD FOR PREPARING THEREOF | Non-Final OA | LG CHEM, LTD. |
| 17642495 | KDM INHIBITORS AND USES THEREOF | Non-Final OA | DANA-FARBER CANCER INSTITUTE, INC. |
| 18476916 | METHODS OF TREATING HIDRADENITIS SUPPURATIVA | Non-Final OA | AbbVie Inc. |
| 18564205 | Selenium Maleimide Compounds And Uses Thereof | Non-Final OA | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL |
| 18002477 | Methods of Treating, Ameliorating, Shortening Duration, and/or Reversing Symptoms and/or Complications of a Coronavirus Infection | Final Rejection | Yale University |
| 17914773 | INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONS | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18569648 | Pharmaceutical Compound | Non-Final OA | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED |
| 18033673 | SALT OF NUCLEOSIDE ANALOG, AND CRYSTAL FORM, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Final Rejection | WUHAN INSTITUTE OF VIROLOGY, CHINESE ACADEMY OF SCIENCES |
| 18017388 | SULFUR-CONTAINING ISOINDOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Non-Final OA | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. |
| 18532573 | COMPOUNDS AND COMPOSITIONS AS c-Kit KINASE INHIBITORS | Non-Final OA | Calixis Inc. |
| 18266103 | Eyedrops for Treating Scleral Thinning and Screening Method for Therapeutic Agent of Scleral Thinning | Non-Final OA | Tsubota Laboratory, Inc. |
| 17788551 | ANTITUMOR DRUG FOR USE IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR | Final Rejection | NIPPON SHINYAKU CO., LTD. |
| 18288888 | METHODS FOR TITRATING MITAPIVAT | Non-Final OA | Agios Pharmaceuticals, Inc. |
| 18006578 | NAPHTHALENE MONOIMIDE COMPOUNDS AND METHODS THEREOF | Non-Final OA | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH |
| 18476247 | Use of an alkaloid compound in the preparation of products for the prevention and/or treatment of cardiac damage | Non-Final OA | NORTHWEST INSTITUTE OF PLATEAU BIOLOGY, CHINESE ACADEMY OF SCIENCES |
| 18280774 | COMPOSITIONS AND METHODS FOR TREATING ANEMIA ASSOCIATED WITH A RIBOSOMAL DISORDER | Non-Final OA | Disc Medicine, Inc. |
| 18262985 | Enhanced Anti-Proliferative and Antitumor Immune Effects of Mitochondria-Targeted Hydroxyurea | Non-Final OA | Aix-Marseille Universite |
| 17920147 | Treatment of Acute Respiratory Distress Syndrome and Other Disorders Involving Cytokine Storm Using BTK Inhibitors | Final Rejection | Principia Biopharma Inc. |
| 18269973 | COMPOSITIONS AND METHODS FOR INDUCING DEFECATION | Non-Final OA | Dignify Therapeutics, LLC |
| 18253384 | COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH | Non-Final OA | Health Research, Inc. |
| 18142751 | ERIODICTYOL COMPOSITIONS AND METHODS | Non-Final OA | CAS PROPERTIES, LLC |
| 18004262 | DEOXYNOJIRIMYCIN DERIVATIVES AS GLUCOSIDASE INHIBITORS | Final Rejection | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. |
| 18028709 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | Non-Final OA | Japan as represented by Director-General of National Institute of Infectious Diseases |
| 18027665 | INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS | Final Rejection | BeOne Medicines I GmbH |
| 18056973 | METHODS AND COMPOSITIONS FOR TREATING ACUTE KIDNEY INJURY | Final Rejection | CalciMedica, Inc. |
| 17918771 | ORAL THIN FILM WITH SMOOTH FUSED FILM | Non-Final OA | LTS LOHMANN THERAPIE-SYSTEME AGE |
| 17761301 | COMPOSITIONS FOR USE IN INHIBITING SRC KINASE AND TREATING AND PREVENTING ASSOCIATED DISORDERS | Final Rejection | Enzene Biosciences Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy